AVE 20.0% 0.3¢ avecho biotechnology limited

New Investor Fact Sheet

  1. 5,867 Posts.
    lightbulb Created with Sketch. 17382
    Phosphagenics has released a new Investor Fact Sheet (dated October 2016) on its website. It reads well, imo.

    Two points of note – firstly, it seems that the two unidentified products being investigated with Terumo are a gel and a spray.

    Secondly, in the section on Production and Personal Care it states that POH has a global distribution agreement with Ashland, supplying TPM and Vital ET as a raw ingredient to multiple commercial partners. In a separate table it refers to Vital-ET based products being currently marketed by Ashland as well as TPM based products partnered with Le Metier + multiple others. ???

    http://www.phosphagenics.com/wp-content/uploads/2016/10/Investor-Fact-Sheet-3-Oct-2016.pdf
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.366K 455.7K

Buyers (Bids)

No. Vol. Price($)
60 99145902 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 22467224 7
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.